DM, MAS, SB, AM, TA, XS, YL, and SG conducted the experiments and analyzed the data
In clinical trials of FDA-approved GLP-1 medications used under medical supervision, some patients achieved average losses consistent with 4 to 8 pounds per month over time, with a total weight loss of roughly 15% to 21% of body weight over the full treatment course
As emphasized by the European Working Group on Sarcopenia in Older People (EWGSOP2), sarcopenia is defined by the combination of low muscle strength and low muscle quantity or quality, with functional impairment as the central determinant of clinical significance [7]
Response to issues How a vendor handles problems reveals more than how they handle routine orders
Unknown Long-Term Effects : Long-term impact on organs, metabolic function, and disease risk has not been established, which creates uncertainty about chronic use